Global Gastrointestinal Stromal Tumor Treatment Market Research Report 2025(Status and Outlook)
Description
Report Overview
The market for gastrointestinal stromal tumor (GIST) treatment focuses on therapies targeting rare mesenchymal tumors that arise in the gastrointestinal tract, primarily driven by mutations in the KIT or PDGFRA genes. Treatment options include tyrosine kinase inhibitors (TKIs) such as imatinib, sunitinib, and regorafenib, which are used as first-, second-, and third-line therapies, respectively, alongside newer drugs like avapritinib and ripretinib for advanced or resistant cases. The market is characterized by increasing prevalence, improved diagnostic techniques, and a growing emphasis on precision medicine, with key players including Novartis, Bayer, and Blueprint Medicines driving innovation. The high cost of targeted therapies and limited treatment options for refractory cases present challenges, while expanding research into combination therapies and novel inhibitors offers significant growth potential. North America and Europe dominate the market due to advanced healthcare infrastructure, but emerging economies are witnessing growth due to rising awareness and improving access to treatment.
The global Gastrointestinal Stromal Tumor Treatment market size was estimated at USD 226.83 million in 2024, exhibiting a CAGR of 5.72% during the forecast period.
This report provides a deep insight into the global Gastrointestinal Stromal Tumor Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal Stromal Tumor Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal Stromal Tumor Treatment market in any manner.
Global Gastrointestinal Stromal Tumor Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
B. Braun Melsungen
Aohua Endoscopy
Olympus
Novartis
Bayer Pharmaceuticals
Glenmark Pharmaceuticals Ltd.
Fortimedix Surgical
Cook Medical
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sonoscape
Huger endoscopy instruments
Bulat Pharmaceutical
MSN Laboratories
Apotex Inc.
Boston Scientific
Arthrex
Johnson & Johnson
CSPC Pharmaceuticals
Hansoh Pharmaceuticals
Kelun Pharmaceuticals
Zai Lab
CStone Pharmaceuticals
China Biopharmaceuticals
Market Segmentation (by Type)
Drugs
Surgery Equipment
Others
Market Segmentation (by Application)
Hospital
Clinic
Pharmacy
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gastrointestinal Stromal Tumor Treatment Market
Overview of the regional outlook of the Gastrointestinal Stromal Tumor Treatment Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumor Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gastrointestinal Stromal Tumor Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The market for gastrointestinal stromal tumor (GIST) treatment focuses on therapies targeting rare mesenchymal tumors that arise in the gastrointestinal tract, primarily driven by mutations in the KIT or PDGFRA genes. Treatment options include tyrosine kinase inhibitors (TKIs) such as imatinib, sunitinib, and regorafenib, which are used as first-, second-, and third-line therapies, respectively, alongside newer drugs like avapritinib and ripretinib for advanced or resistant cases. The market is characterized by increasing prevalence, improved diagnostic techniques, and a growing emphasis on precision medicine, with key players including Novartis, Bayer, and Blueprint Medicines driving innovation. The high cost of targeted therapies and limited treatment options for refractory cases present challenges, while expanding research into combination therapies and novel inhibitors offers significant growth potential. North America and Europe dominate the market due to advanced healthcare infrastructure, but emerging economies are witnessing growth due to rising awareness and improving access to treatment.
The global Gastrointestinal Stromal Tumor Treatment market size was estimated at USD 226.83 million in 2024, exhibiting a CAGR of 5.72% during the forecast period.
This report provides a deep insight into the global Gastrointestinal Stromal Tumor Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal Stromal Tumor Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal Stromal Tumor Treatment market in any manner.
Global Gastrointestinal Stromal Tumor Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
B. Braun Melsungen
Aohua Endoscopy
Olympus
Novartis
Bayer Pharmaceuticals
Glenmark Pharmaceuticals Ltd.
Fortimedix Surgical
Cook Medical
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sonoscape
Huger endoscopy instruments
Bulat Pharmaceutical
MSN Laboratories
Apotex Inc.
Boston Scientific
Arthrex
Johnson & Johnson
CSPC Pharmaceuticals
Hansoh Pharmaceuticals
Kelun Pharmaceuticals
Zai Lab
CStone Pharmaceuticals
China Biopharmaceuticals
Market Segmentation (by Type)
Drugs
Surgery Equipment
Others
Market Segmentation (by Application)
Hospital
Clinic
Pharmacy
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gastrointestinal Stromal Tumor Treatment Market
Overview of the regional outlook of the Gastrointestinal Stromal Tumor Treatment Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumor Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gastrointestinal Stromal Tumor Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
192 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Gastrointestinal Stromal Tumor Treatment
- 1.2 Key Market Segments
- 1.2.1 Gastrointestinal Stromal Tumor Treatment Segment by Type
- 1.2.2 Gastrointestinal Stromal Tumor Treatment Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Gastrointestinal Stromal Tumor Treatment Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Gastrointestinal Stromal Tumor Treatment Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Gastrointestinal Stromal Tumor Treatment Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Gastrointestinal Stromal Tumor Treatment Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Gastrointestinal Stromal Tumor Treatment Product Life Cycle
- 3.3 Global Gastrointestinal Stromal Tumor Treatment Sales by Manufacturers (2020-2025)
- 3.4 Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Gastrointestinal Stromal Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Gastrointestinal Stromal Tumor Treatment Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Gastrointestinal Stromal Tumor Treatment Market Competitive Situation and Trends
- 3.8.1 Gastrointestinal Stromal Tumor Treatment Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Gastrointestinal Stromal Tumor Treatment Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Gastrointestinal Stromal Tumor Treatment Industry Chain Analysis
- 4.1 Gastrointestinal Stromal Tumor Treatment Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Gastrointestinal Stromal Tumor Treatment Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Gastrointestinal Stromal Tumor Treatment Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Gastrointestinal Stromal Tumor Treatment Market
- 5.7 ESG Ratings of Leading Companies
- 6 Gastrointestinal Stromal Tumor Treatment Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Gastrointestinal Stromal Tumor Treatment Sales Market Share by Type (2020-2025)
- 6.3 Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2020-2025)
- 6.4 Global Gastrointestinal Stromal Tumor Treatment Price by Type (2020-2025)
- 7 Gastrointestinal Stromal Tumor Treatment Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Gastrointestinal Stromal Tumor Treatment Market Sales by Application (2020-2025)
- 7.3 Global Gastrointestinal Stromal Tumor Treatment Market Size (M USD) by Application (2020-2025)
- 7.4 Global Gastrointestinal Stromal Tumor Treatment Sales Growth Rate by Application (2020-2025)
- 8 Gastrointestinal Stromal Tumor Treatment Market Sales by Region
- 8.1 Global Gastrointestinal Stromal Tumor Treatment Sales by Region
- 8.1.1 Global Gastrointestinal Stromal Tumor Treatment Sales by Region
- 8.1.2 Global Gastrointestinal Stromal Tumor Treatment Sales Market Share by Region
- 8.2 Global Gastrointestinal Stromal Tumor Treatment Market Size by Region
- 8.2.1 Global Gastrointestinal Stromal Tumor Treatment Market Size by Region
- 8.2.2 Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Gastrointestinal Stromal Tumor Treatment Sales by Country
- 8.3.2 North America Gastrointestinal Stromal Tumor Treatment Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Gastrointestinal Stromal Tumor Treatment Sales by Country
- 8.4.2 Europe Gastrointestinal Stromal Tumor Treatment Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Gastrointestinal Stromal Tumor Treatment Sales by Region
- 8.5.2 Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Gastrointestinal Stromal Tumor Treatment Sales by Country
- 8.6.2 South America Gastrointestinal Stromal Tumor Treatment Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Gastrointestinal Stromal Tumor Treatment Sales by Region
- 8.7.2 Middle East and Africa Gastrointestinal Stromal Tumor Treatment Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Gastrointestinal Stromal Tumor Treatment Market Production by Region
- 9.1 Global Production of Gastrointestinal Stromal Tumor Treatment by Region(2020-2025)
- 9.2 Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Region (2020-2025)
- 9.3 Global Gastrointestinal Stromal Tumor Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Gastrointestinal Stromal Tumor Treatment Production
- 9.4.1 North America Gastrointestinal Stromal Tumor Treatment Production Growth Rate (2020-2025)
- 9.4.2 North America Gastrointestinal Stromal Tumor Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Gastrointestinal Stromal Tumor Treatment Production
- 9.5.1 Europe Gastrointestinal Stromal Tumor Treatment Production Growth Rate (2020-2025)
- 9.5.2 Europe Gastrointestinal Stromal Tumor Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Gastrointestinal Stromal Tumor Treatment Production (2020-2025)
- 9.6.1 Japan Gastrointestinal Stromal Tumor Treatment Production Growth Rate (2020-2025)
- 9.6.2 Japan Gastrointestinal Stromal Tumor Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Gastrointestinal Stromal Tumor Treatment Production (2020-2025)
- 9.7.1 China Gastrointestinal Stromal Tumor Treatment Production Growth Rate (2020-2025)
- 9.7.2 China Gastrointestinal Stromal Tumor Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 B. Braun Melsungen
- 10.1.1 B. Braun Melsungen Basic Information
- 10.1.2 B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.1.3 B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.1.4 B. Braun Melsungen Business Overview
- 10.1.5 B. Braun Melsungen SWOT Analysis
- 10.1.6 B. Braun Melsungen Recent Developments
- 10.2 Aohua Endoscopy
- 10.2.1 Aohua Endoscopy Basic Information
- 10.2.2 Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.2.3 Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.2.4 Aohua Endoscopy Business Overview
- 10.2.5 Aohua Endoscopy SWOT Analysis
- 10.2.6 Aohua Endoscopy Recent Developments
- 10.3 Olympus
- 10.3.1 Olympus Basic Information
- 10.3.2 Olympus Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.3.3 Olympus Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.3.4 Olympus Business Overview
- 10.3.5 Olympus SWOT Analysis
- 10.3.6 Olympus Recent Developments
- 10.4 Novartis
- 10.4.1 Novartis Basic Information
- 10.4.2 Novartis Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.4.3 Novartis Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.4.4 Novartis Business Overview
- 10.4.5 Novartis Recent Developments
- 10.5 Bayer Pharmaceuticals
- 10.5.1 Bayer Pharmaceuticals Basic Information
- 10.5.2 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.5.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.5.4 Bayer Pharmaceuticals Business Overview
- 10.5.5 Bayer Pharmaceuticals Recent Developments
- 10.6 Glenmark Pharmaceuticals Ltd.
- 10.6.1 Glenmark Pharmaceuticals Ltd. Basic Information
- 10.6.2 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.6.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.6.4 Glenmark Pharmaceuticals Ltd. Business Overview
- 10.6.5 Glenmark Pharmaceuticals Ltd. Recent Developments
- 10.7 Fortimedix Surgical
- 10.7.1 Fortimedix Surgical Basic Information
- 10.7.2 Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.7.3 Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.7.4 Fortimedix Surgical Business Overview
- 10.7.5 Fortimedix Surgical Recent Developments
- 10.8 Cook Medical
- 10.8.1 Cook Medical Basic Information
- 10.8.2 Cook Medical Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.8.3 Cook Medical Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.8.4 Cook Medical Business Overview
- 10.8.5 Cook Medical Recent Developments
- 10.9 Actavis Generics
- 10.9.1 Actavis Generics Basic Information
- 10.9.2 Actavis Generics Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.9.3 Actavis Generics Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.9.4 Actavis Generics Business Overview
- 10.9.5 Actavis Generics Recent Developments
- 10.10 Dr. Reddy's Laboratories
- 10.10.1 Dr. Reddy's Laboratories Basic Information
- 10.10.2 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.10.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.10.4 Dr. Reddy's Laboratories Business Overview
- 10.10.5 Dr. Reddy's Laboratories Recent Developments
- 10.11 Teva Pharmaceutical Industries Ltd.
- 10.11.1 Teva Pharmaceutical Industries Ltd. Basic Information
- 10.11.2 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.11.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.11.4 Teva Pharmaceutical Industries Ltd. Business Overview
- 10.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
- 10.12 Sonoscape
- 10.12.1 Sonoscape Basic Information
- 10.12.2 Sonoscape Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.12.3 Sonoscape Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.12.4 Sonoscape Business Overview
- 10.12.5 Sonoscape Recent Developments
- 10.13 Huger endoscopy instruments
- 10.13.1 Huger endoscopy instruments Basic Information
- 10.13.2 Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.13.3 Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.13.4 Huger endoscopy instruments Business Overview
- 10.13.5 Huger endoscopy instruments Recent Developments
- 10.14 Bulat Pharmaceutical
- 10.14.1 Bulat Pharmaceutical Basic Information
- 10.14.2 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.14.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.14.4 Bulat Pharmaceutical Business Overview
- 10.14.5 Bulat Pharmaceutical Recent Developments
- 10.15 MSN Laboratories
- 10.15.1 MSN Laboratories Basic Information
- 10.15.2 MSN Laboratories Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.15.3 MSN Laboratories Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.15.4 MSN Laboratories Business Overview
- 10.15.5 MSN Laboratories Recent Developments
- 10.16 Apotex Inc.
- 10.16.1 Apotex Inc. Basic Information
- 10.16.2 Apotex Inc. Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.16.3 Apotex Inc. Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.16.4 Apotex Inc. Business Overview
- 10.16.5 Apotex Inc. Recent Developments
- 10.17 Boston Scientific
- 10.17.1 Boston Scientific Basic Information
- 10.17.2 Boston Scientific Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.17.3 Boston Scientific Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.17.4 Boston Scientific Business Overview
- 10.17.5 Boston Scientific Recent Developments
- 10.18 Arthrex
- 10.18.1 Arthrex Basic Information
- 10.18.2 Arthrex Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.18.3 Arthrex Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.18.4 Arthrex Business Overview
- 10.18.5 Arthrex Recent Developments
- 10.19 Johnson and Johnson
- 10.19.1 Johnson and Johnson Basic Information
- 10.19.2 Johnson and Johnson Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.19.3 Johnson and Johnson Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.19.4 Johnson and Johnson Business Overview
- 10.19.5 Johnson and Johnson Recent Developments
- 10.20 CSPC Pharmaceuticals
- 10.20.1 CSPC Pharmaceuticals Basic Information
- 10.20.2 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.20.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.20.4 CSPC Pharmaceuticals Business Overview
- 10.20.5 CSPC Pharmaceuticals Recent Developments
- 10.21 Hansoh Pharmaceuticals
- 10.21.1 Hansoh Pharmaceuticals Basic Information
- 10.21.2 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.21.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.21.4 Hansoh Pharmaceuticals Business Overview
- 10.21.5 Hansoh Pharmaceuticals Recent Developments
- 10.22 Kelun Pharmaceuticals
- 10.22.1 Kelun Pharmaceuticals Basic Information
- 10.22.2 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.22.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.22.4 Kelun Pharmaceuticals Business Overview
- 10.22.5 Kelun Pharmaceuticals Recent Developments
- 10.23 Zai Lab
- 10.23.1 Zai Lab Basic Information
- 10.23.2 Zai Lab Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.23.3 Zai Lab Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.23.4 Zai Lab Business Overview
- 10.23.5 Zai Lab Recent Developments
- 10.24 CStone Pharmaceuticals
- 10.24.1 CStone Pharmaceuticals Basic Information
- 10.24.2 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.24.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.24.4 CStone Pharmaceuticals Business Overview
- 10.24.5 CStone Pharmaceuticals Recent Developments
- 10.25 China Biopharmaceuticals
- 10.25.1 China Biopharmaceuticals Basic Information
- 10.25.2 China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Overview
- 10.25.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Market Performance
- 10.25.4 China Biopharmaceuticals Business Overview
- 10.25.5 China Biopharmaceuticals Recent Developments
- 11 Gastrointestinal Stromal Tumor Treatment Market Forecast by Region
- 11.1 Global Gastrointestinal Stromal Tumor Treatment Market Size Forecast
- 11.2 Global Gastrointestinal Stromal Tumor Treatment Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Gastrointestinal Stromal Tumor Treatment Market Size Forecast by Country
- 11.2.3 Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Size Forecast by Region
- 11.2.4 South America Gastrointestinal Stromal Tumor Treatment Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Gastrointestinal Stromal Tumor Treatment by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Gastrointestinal Stromal Tumor Treatment Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor Treatment by Type (2026-2033)
- 12.1.2 Global Gastrointestinal Stromal Tumor Treatment Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Gastrointestinal Stromal Tumor Treatment by Type (2026-2033)
- 12.2 Global Gastrointestinal Stromal Tumor Treatment Market Forecast by Application (2026-2033)
- 12.2.1 Global Gastrointestinal Stromal Tumor Treatment Sales (K MT) Forecast by Application
- 12.2.2 Global Gastrointestinal Stromal Tumor Treatment Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
